Follow the PegBio Co., Ltd. - B - H Shares stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Market capitalisation: €2.2bn. The latest transaction was filed on 2 July 2026 (Other). Among the most active insiders: XU Michael Min. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
PegBio Co., Ltd. is a company focused on the development of biopharmaceutical products. It specializes in the research and commercialization of innovative treatments for various diseases.